UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 142,575 Shares of Docusign Inc. $DOCU

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 7.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,808,071 shares of the company’s stock after selling 142,575 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.95% of Docusign worth $80,315,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOCU. Modus Advisors LLC bought a new position in shares of Docusign in the fourth quarter worth $27,000. Cary Street Partners Investment Advisory LLC raised its position in Docusign by 309.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company’s stock worth $38,000 after purchasing an additional 424 shares during the period. Basepoint Wealth LLC purchased a new position in shares of Docusign in the fourth quarter worth about $39,000. WealthCollab LLC increased its stake in Docusign by 372.4% in the 1st quarter. WealthCollab LLC now owns 855 shares of the company’s stock worth $41,000 after purchasing an additional 674 shares during the period. Finally, Virtus Advisers LLC purchased a new position in shares of Docusign in the second quarter worth $47,000. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 15,000 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the transaction, the chief financial officer directly owned 126,429 shares of the company’s stock, valued at approximately $7,585,740. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the transaction, the insider owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 90,965 shares of company stock valued at $4,341,688 in the last ninety days. Company insiders own 0.59% of the company’s stock.

Docusign Stock Performance

Shares of DOCU stock opened at $65.39 on Thursday. The stock has a fifty day simple moving average of $54.77 and a two-hundred day simple moving average of $49.59. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $86.65. The firm has a market capitalization of $12.49 billion, a PE ratio of 42.46, a PEG ratio of 2.27 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last issued its earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The company had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. During the same quarter last year, the company earned $0.90 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. On average, sell-side analysts forecast that Docusign Inc. will post 2.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DOCU has been the subject of a number of recent analyst reports. Wall Street Zen lowered Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research report on Friday, June 5th. Jefferies Financial Group lifted their price objective on Docusign from $45.00 to $50.00 and gave the company a “hold” rating in a research note on Friday, June 5th. UBS Group set a $60.00 target price on shares of Docusign in a report on Friday, June 5th. Finally, Weiss Ratings upgraded Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 25th. Four equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $61.27.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.